Multiple system atrophy mimicked by multi-organ pathology.

Published on Aug 1, 2019in Practical Neurology
· DOI :10.1136/PRACTNEUROL-2019-002233
Sana Khan1
Estimated H-index: 1
(University of Leeds),
Gnanamurthy Sivakumar1
Estimated H-index: 1
(Leeds Teaching Hospitals NHS Trust)
+ 1 AuthorsJane E. Alty12
Estimated H-index: 12
(Leeds Teaching Hospitals NHS Trust)
Both multiple system atrophy and Parkinson’s disease may present with parkinsonism and autonomic dysfunction. We describe a patient who initially met the diagnostic criteria for multiple system atrophy and had atypical features for Parkinson’s disease including blackouts and pyramidal signs. Ultimately, he was found to have three separate diagnoses rather than a single unifying one.
📖 Papers frequently viewed together
19 Citations
#1Naveed MalekH-Index: 16
#2Michael A Lawton (UoB: University of Bristol)H-Index: 16
Last. Donald G. GrossetH-Index: 56
view all 13 authors...
Background Autonomic dysfunction is common in the later stages of Parkinson's disease (PD), but less is known about its presence and severity in early disease. Objective To analyze features of autonomic dysfunction in recent onset PD cases, and their relationship to motor severity, medication use, other nonmotor symptoms (NMS), and quality-of-life scores. Methods Detailed patient-reported symptoms of autonomic dysfunction were assessed in a multicenter cohort study in PD cases that had been diag...
15 CitationsSource
#1Claire L Tomlinson (University of Birmingham)H-Index: 9
#2Rebecca Stowe (University of Birmingham)H-Index: 19
Last. Carl E Clarke (University of Birmingham)H-Index: 58
view all 6 authors...
Interpretation of clinical trials comparing different drug regimens for Parkinson's disease (PD) is complicated by the different dose intensities used: higher doses of levodopa and, possibly, other drugs produce better symptomatic control but more late complications. To address this problem, conversion factors have been calculated for antiparkinsonian drugs that yield a total daily levodopa equivalent dose (LED). LED estimates vary, so we undertook a systematic review of studies reporting LEDs t...
3,207 CitationsSource
#1Sid Gilman (UM: University of Michigan)H-Index: 79
#2Gregor K. Wenning (Innsbruck Medical University)H-Index: 111
Last. Marie Vidailhet (UPMC: Pierre-and-Marie-Curie University)H-Index: 87
view all 20 authors...
Background: A consensus conference on multiple system atrophy (MSA) in 1998 established criteria for diagnosis that have been accepted widely. Since then, clinical, laboratory, neuropathologic, and imaging studies have advanced the field, requiring a fresh evaluation of diagnostic criteria. We held a second consensus conference in 2007 and present the results here.Methods: Experts in the clinical, neuropathologic, and imaging aspects of MSA were invited to participate in a 2-day consensus confer...
2,135 CitationsSource
Cited By1
#1Neziha ErkenH-Index: 1
#2Ahmet Turan IsikH-Index: 23